Pathological pain, consisting of tissue injury-induced inflammatory and nerve injury-induced neuropathic pain, is an expression of neuronal plasticity. One component of this is that the afferent input generated by injury and intense noxious stimuli triggers an increased excitability of nociceptive neurons in the spinal cord. This central sensitization is an activity-dependent functional plasticity that results from activation of different intracellular kinase cascades leading to the phosphorylation of key membrane receptors and channels, increasing synaptic efficacy. Central sensitization is both induced and maintained in a transcription-independent manner. Several different intracellular signal transduction cascades converge on MAPK (mitogen-activated protein kinase), activation of which appears to be a master switch or gate for the regulation of central sensitization. In addition to posttranslational regulation, the MAPK pathway may also regulate long-term pain hypersensitivity, via transcriptional regulation of key gene products. Pharmacological intervention targeted specifically at the signal transduction pathways in nociceptive neurons may provide, therefore, new therapeutic opportunities for pathological pain.
INTRODUCTION
Activation of the peripheral terminals of nociceptive primary afferents, including both unmyelinated Cfibers and light-myelinated A␦ fibers by high intensity peripheral stimuli, has several different functional consequences, operating at different times, in central neurons. First, it generates, after conduction of action potentials to the central terminals of the nociceptors fast synaptic currents in dorsal horn neurons that are mediated by AMPA/kainate receptors and boosted by NMDA receptors that last for tens of milliseconds and encode information about the onset, intensity, quality, location, and duration of the noxious stimulus. This neural activation pattern is transferred from the spinal cord via the thalamus to the cortex where it leads to an acute pain sensation which has an adaptive protective role, warning of potential tissue damage (physiological pain).
Activation of peripheral nociceptors also results in an activity-or use-dependent neuronal plasticity in the spinal cord that modifies the subsequent performance of the nociceptive pathway by exaggerating or prolonging the response to noxious inputs (hyperalgesia) and enabling normally innocuous inputs to activate it (allodynia). This activity-dependent plasticity is the consequence initially of the summation of Cfiber evoked slow synaptic currents produced by glutamate acting on NMDA and mGluR receptors, and neuropeptides, such as substance P acting via their G-protein coupled receptors, as well as by the recruitment of postsynaptic voltage-gated calcium plateau currents. These synaptic and voltage-gated currents contribute to a use-dependent facilitation (windup) of
